Cargando…

Development assistance for health and the Middle East and North Africa

BACKGROUND: Donor countries in the Middle East and North Africa (MENA) including Saudi Arabia, Kuwait and United Arab Emirates (UAE) have been among the largest donors in the world. However, little is known about their contributions for health. In this study, we addressed this gap by estimating the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yingxi, Micah, Angela E., Gloyd, Stephen, Dieleman, Joseph L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001325/
https://www.ncbi.nlm.nih.gov/pubmed/32019554
http://dx.doi.org/10.1186/s12992-020-0545-z
_version_ 1783494219800772608
author Zhao, Yingxi
Micah, Angela E.
Gloyd, Stephen
Dieleman, Joseph L.
author_facet Zhao, Yingxi
Micah, Angela E.
Gloyd, Stephen
Dieleman, Joseph L.
author_sort Zhao, Yingxi
collection PubMed
description BACKGROUND: Donor countries in the Middle East and North Africa (MENA) including Saudi Arabia, Kuwait and United Arab Emirates (UAE) have been among the largest donors in the world. However, little is known about their contributions for health. In this study, we addressed this gap by estimating the amount of development assistance for health (DAH) contributed by MENA country donors from 2000 to 2017. METHODS: We tracked DAH provided and received by the MENA region leveraging publicly available development assistance data in the Development Assistance Committee (DAC) database of the Organisation for Economic Co-operation and Development (OECD), government agency reports and financial statements from key international development agencies. We generated estimates of DAH provided by the three largest donor countries in the MENA region (UAE, Kuwait, Saudi Arabia) and compared contributions to their relative gross domestic product (GDP) and government spending; We captured DAH contributions by other MENA country governments (Egypt, Iran, Qatar, Turkey, etc.) disbursed through multilateral agencies. Additionally, we compared DAH contributed from and provided to the MENA region. RESULTS: In 2017, DAH contributed by the MENA region reached $514.8 million. While UAE ($220.1 million, 43.2%), Saudi Arabia ($177.3 million, 34.8%) and Kuwait ($59.8 million, 11.6%) as sources contributed the majority of DAH in 2017, 58.5% of total DAH from MENA was disbursed through their bilateral agencies, 12.0% through the World Health Organization (WHO) and 3.3% through other United Nations agencies. 44.8% of DAH contributions from MENA was directed to health system strengthening/sector-wide approaches. Relative to their GDP and government spending, DAH level fluctuated across 2000 to 2017 but UAE and Saudi Arabia indicated increasing trends. While considering all MENA countries as recipients, only 10.5% of DAH received by MENA countries were from MENA donors in 2017. CONCLUSION: MENA country donors especially UAE, Saudi Arabia and Kuwait have been providing substantial amount of DAH, channeled through their bilateral agencies, WHO and other multilateral agencies, with a prioritized focus on health system strengthening. DAH from the MENA region has been increasing for the past decade and could lend itself to important contributions for the region and the globe.
format Online
Article
Text
id pubmed-7001325
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-70013252020-02-10 Development assistance for health and the Middle East and North Africa Zhao, Yingxi Micah, Angela E. Gloyd, Stephen Dieleman, Joseph L. Global Health Research BACKGROUND: Donor countries in the Middle East and North Africa (MENA) including Saudi Arabia, Kuwait and United Arab Emirates (UAE) have been among the largest donors in the world. However, little is known about their contributions for health. In this study, we addressed this gap by estimating the amount of development assistance for health (DAH) contributed by MENA country donors from 2000 to 2017. METHODS: We tracked DAH provided and received by the MENA region leveraging publicly available development assistance data in the Development Assistance Committee (DAC) database of the Organisation for Economic Co-operation and Development (OECD), government agency reports and financial statements from key international development agencies. We generated estimates of DAH provided by the three largest donor countries in the MENA region (UAE, Kuwait, Saudi Arabia) and compared contributions to their relative gross domestic product (GDP) and government spending; We captured DAH contributions by other MENA country governments (Egypt, Iran, Qatar, Turkey, etc.) disbursed through multilateral agencies. Additionally, we compared DAH contributed from and provided to the MENA region. RESULTS: In 2017, DAH contributed by the MENA region reached $514.8 million. While UAE ($220.1 million, 43.2%), Saudi Arabia ($177.3 million, 34.8%) and Kuwait ($59.8 million, 11.6%) as sources contributed the majority of DAH in 2017, 58.5% of total DAH from MENA was disbursed through their bilateral agencies, 12.0% through the World Health Organization (WHO) and 3.3% through other United Nations agencies. 44.8% of DAH contributions from MENA was directed to health system strengthening/sector-wide approaches. Relative to their GDP and government spending, DAH level fluctuated across 2000 to 2017 but UAE and Saudi Arabia indicated increasing trends. While considering all MENA countries as recipients, only 10.5% of DAH received by MENA countries were from MENA donors in 2017. CONCLUSION: MENA country donors especially UAE, Saudi Arabia and Kuwait have been providing substantial amount of DAH, channeled through their bilateral agencies, WHO and other multilateral agencies, with a prioritized focus on health system strengthening. DAH from the MENA region has been increasing for the past decade and could lend itself to important contributions for the region and the globe. BioMed Central 2020-02-04 /pmc/articles/PMC7001325/ /pubmed/32019554 http://dx.doi.org/10.1186/s12992-020-0545-z Text en © The Author(s). 2020 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Zhao, Yingxi
Micah, Angela E.
Gloyd, Stephen
Dieleman, Joseph L.
Development assistance for health and the Middle East and North Africa
title Development assistance for health and the Middle East and North Africa
title_full Development assistance for health and the Middle East and North Africa
title_fullStr Development assistance for health and the Middle East and North Africa
title_full_unstemmed Development assistance for health and the Middle East and North Africa
title_short Development assistance for health and the Middle East and North Africa
title_sort development assistance for health and the middle east and north africa
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001325/
https://www.ncbi.nlm.nih.gov/pubmed/32019554
http://dx.doi.org/10.1186/s12992-020-0545-z
work_keys_str_mv AT zhaoyingxi developmentassistanceforhealthandthemiddleeastandnorthafrica
AT micahangelae developmentassistanceforhealthandthemiddleeastandnorthafrica
AT gloydstephen developmentassistanceforhealthandthemiddleeastandnorthafrica
AT dielemanjosephl developmentassistanceforhealthandthemiddleeastandnorthafrica